Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
This study is ongoing, but not recruiting participants.
First Received: June 2, 2000   Last Updated: June 23, 2005   History of Changes
Sponsored by: Fairview University Medical Center
Information provided by: Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier: NCT00005900
  Purpose

OBJECTIVES: I. Evaluate bronchoalveolar lavage fluid and serum obtained from pediatric patients with storage disorders prior to allogeneic hematopoietic stem cell transplantation (HSCT) for the presence of proinflammatory cytokines and for the production of nitric oxide by alveolar macrophages to identify possible risk factors for pulmonary complications. II. Investigate the underlying mechanism for the development of significant pulmonary complications in these patients during HSCT.

III. Evaluate bronchoalveolar lavage fluid and serum obtained from these same patients at the time a pulmonary complication develops post-HSCT, or at 60 days post-HSCT if there has been no pulmonary complications.


Condition
I Cell Disease
Fucosidosis
Globoid Cell Leukodystrophy
Adrenoleukodystrophy
Mannosidosis
Niemann-Pick Disease
Pulmonary Complications
Mucopolysaccharidosis I
Mucopolysaccharidosis VI
Metachromatic Leukodystrophy
Gaucher's Disease
Wolman Disease

Genetics Home Reference related topics: alpha-mannosidosis beta-ketothiolase deficiency Chanarin-Dorfman syndrome cholesteryl ester storage disease Farber lipogranulomatosis fucosidosis Gaucher disease Krabbe disease L1 syndrome leukoencephalopathy with vanishing white matter long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency megalencephalic leukoencephalopathy with subcortical cysts metachromatic leukodystrophy mitochondrial trifunctional protein deficiency mucopolysaccharidosis type I Niemann-Pick disease primary carnitine deficiency succinic semialdehyde dehydrogenase deficiency Wolman disease X-linked adrenoleukodystrophy
MedlinePlus related topics: Addison's Disease Gaucher's Disease Leukodystrophies
U.S. FDA Resources
Study Type: Observational
Study Design: Screening

Further study details as provided by Office of Rare Diseases (ORD):

Estimated Enrollment: 10
Study Start Date: August 1999
Detailed Description:

PROTOCOL OUTLINE:

Patients undergo bronchoscopy with bronchoalveolar lavage (BAL) prior to allogeneic hematopoietic stem cell transplantation (HSCT). ELISA assays for cytokines are performed. Patients are followed post-HSCT for the development of transplant related pulmonary complications. A repeat bronchoscopy with BAL is performed at the time pulmonary complications develop or at day 60 post-HSCT if no complications develop. Cytokine assays are repeated.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • Diagnosis of an inborn error of metabolism eligible for allogeneic hematopoietic stem cell transplantation on protocol UMN-MT-1995-01
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00005900

Locations
United States, Minnesota
Fairview University Medical Center
Minneapolis, Minnesota, United States, 55455
Sponsors and Collaborators
Fairview University Medical Center
Investigators
Study Chair: K. Scott Baker Fairview University Medical Center
  More Information

No publications provided

Study ID Numbers: 199/15111, UMN-MT-1999-18, UMN-MT-9818
Study First Received: June 2, 2000
Last Updated: June 23, 2005
ClinicalTrials.gov Identifier: NCT00005900     History of Changes
Health Authority: Unspecified

Keywords provided by Office of Rare Diseases (ORD):
Gaucher's disease
I cell disease
Niemann-Pick disease
Wolman disease
adrenoleukodystrophy
disease-related problem/condition
fucosidosis
genetic diseases and dysmorphic syndromes
globoid cell leukodystrophy
inborn errors of metabolism
mannosidosis
metachromatic leukodystrophy
mucopolysaccharidosis
mucopolysaccharidosis I
mucopolysaccharidosis VI
oncologic disorders
pulmonary complications
rare disease
sphingolipidoses

Study placed in the following topic categories:
Metachromatic Leukodystrophy
Pick Disease of the Brain
Sphingolipidoses
I Cell Disease
Adrenal Gland Diseases
Hypoadrenalism
Brain Diseases
X-linked Adrenoleukodystrophy
Metabolism, Inborn Errors
Mucopolysaccharidoses
Heredodegenerative Disorders, Nervous System
Frontotemporal Dementia
Adrenoleukodystrophy
Addison Disease
Infant, Newborn, Diseases
Brain Diseases, Metabolic, Inborn
Metabolic Disorder
Niemann-Pick Disease
Delirium
Speech Disorders
Adrenal Insufficiency
Cholesterol Ester Storage Disease
Metabolic Diseases
Demyelinating Diseases
Lysosomal Storage Diseases
Aphasia
Language Disorders
Endocrine System Diseases
Cognition Disorders
Fucosidosis

Additional relevant MeSH terms:
Pick Disease of the Brain
Sphingolipidoses
Adrenal Gland Diseases
Brain Diseases
Mucinoses
Hereditary Central Nervous System Demyelinating Diseases
Metabolism, Inborn Errors
Mucopolysaccharidoses
Heredodegenerative Disorders, Nervous System
Adrenoleukodystrophy
Addison Disease
Infant, Newborn, Diseases
Brain Diseases, Metabolic, Inborn
Speech Disorders
Adrenal Insufficiency
Cholesterol Ester Storage Disease
Metabolic Diseases
Reticuloendotheliosis
Immune System Diseases
Demyelinating Diseases
Aphasia
Lysosomal Storage Diseases
Nervous System Diseases
Sulfatidosis
Language Disorders
Endocrine System Diseases
Fucosidosis
Mental Retardation
Niemann-Pick Disease, Type C
Delirium, Dementia, Amnestic, Cognitive Disorders

ClinicalTrials.gov processed this record on May 07, 2009